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Design and methods for a randomized clinical
trial comparing three outreach efforts to improve
screening mammography adherence
Mary E Costanza1*, Roger Luckmann2, Mary Jo White2, Milagros C Rosal1, Caroline Cranos2, George Reed1,
Robin Clark3, Susan Sama4 and Robert Yood4
Abstract
Background: Despite the demonstrated need to increase screening mammography utilization and strong
evidence that mail and telephone outreach to women can increase screening, most managed care organizations
have not adopted comprehensive outreach programs. The uncertainty about optimum strategies and cost
effectiveness have retarded widespread acceptance. While 70% of women report getting a mammogram within
the prior 2 years, repeat mammography rates are less than 50%. This 5-year study is conducted though a Central
Massachusetts healthcare plan and affiliated clinic. All womenhave adequate health insurance to cover the test.
Methods/Design: This randomized study compares 3 arms: reminder letter alone; reminder letter plus reminder call;
reminder letter plus a second reminder and booklet plus a counselor call. All calls provide women with the opportunity
to schedule a mammogram in a reasonable time. The invention period will span 4 years and include repeat attempts.
The counselor arm is designed to educate, motivate and counsel women in an effort to alleviate PCP burden.
All women who have been in the healthcare plan for 24 months and who have a current primary care provider
(PCP) and who are aged 51-84 are randomized to 1 of 3 arms. Interventions are limited to women who become
≥18 months from a prior mammogram. Women and their physicians may opt out of the intervention study.
Measurement of completed mammograms will use plan billing records and clinic electronic records. The primary
outcome is the proportion of women continuously enrolled for ≥24 months who have had ≥1 mammogram in
the last 24 months. Secondary outcomes include the number of women who need repeat interventions. The cost
effectiveness analysis will measure all costs from the provider perspective.
Discussion: So far, 18,509 women aged 51-84 have been enrolled into our tracking database and were
randomized into one of three arms. At baseline, 5,223 women were eligible for an intervention. We anticipate that
the outcome will provide firm data about the maximal effectiveness as well as the cost effectiveness of the
interventions both for increasing the mammography rate and the repeat mammography rate.
Trial registration: http://clinicaltrials.gov/NCT01332032
Background
Despite the demonstrated need to increase screening
mammography utilization and the strong evidence that
mail and telephone outreach to women can increase
screening in the short term, most managed care organi-
zations have not adopted comprehensive outreach
programs for several reasons: 1) the continuing uncer-
tainty about optimum outreach strategy, 2) the absence
of practical and replicable models of such systems and
3) the lack of cost effectiveness data to guide decision-
making. We undertook this study to compare three suc-
cessful methods of promoting regular screening mam-
mography (mailed reminders, reminder calls, and more
intensive counseling calls) and to identify the most
effective and most cost effective of these outreach stra-
tegies. Our findings should provide much needed and
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timely guidance for health plans [1] and Accountable
Care Organizations (ACOs).
Determining the most effective way to reach women
remains an urgent yet unfinished task. Although public
health efforts have been promoting mammography for
25 years or more, national screening rates appear to
have stalled. While 81% of American women, 50-74,
report having a mammogram in the previous two years
[2], only 46% woman get them regularly every 1-2 years
[3]. A suboptimal level of screening is of considerable
concern because the reduction in breast cancer mortal-
ity seen with screening mammography requires repeat
mammography every several years [4,5]. Non-adherent
women are at increased risk for developing advanced or
non-curable breast cancers when compared to adherent
women [6].
The three arms of the study are:
1) RL: A mailed reminder to schedule a mammogram.
Mailed reminders have been shown to increase screen-
ing mammography rates by 25-50% [7-11] and have
become usual care in some managed care organizations.
2) RC: A mailed reminder followed, if no response, by
a reminder telephone call with facilitated access to
mammography scheduling. Reminder calls have gener-
ally been more effective than reminder letters, especially
when the former include the opportunity to schedule a
mammogram [12,13]. It is important to confirm this
finding in a large population of non-adherent women
and especially in women long overdue for a
mammogram.
3). ETTC: A mailed reminder followed, if no response,
by a mailed educational booklet and, if still no response,
by an enhanced tailored telephone counseling call
(ETTC). Standard tailored telephone counseling (TTC)
has been effective in a wide variety of health promotion
outreach efforts [14-21] including efforts focused on
cancer prevention and screening [22-25], breast cancer
prevention [26] and breast cancer screening [27-33].
TTC has been most effective in breast cancer screening
studies when it is used with women who have had a
prior mammogram or a recent mammogram but less so
in women who had never had a mammogram [27].
Overall, TTC interventions show an improvement in
mammography completion rates over mailed reminders
or mailed educational materials [13,34-37]. While TTC
is often confined to tailored barriers [38], reluctant
women may need more encouragement. We developed
an enhanced TTC (ETTC) by adding techniques from
motivational interviewing [39-43], informative print
material and the ability to schedule mammogram on the
call. We have pilot tested ETTC and it is effective in
helping long overdue women schedule and complete
screening mammograms [44,45].
Study goals
The study goals are:
1) To compare the effectiveness of the three outreach
interventions in increasing adherence to mammography
screening guidelines in a large managed care population.
2) To identify ways to improve the efficiency and
sequencing of the interventions by identifying patient
factors and intervention mechanisms associated with
increased intervention effectiveness through the eva-
luation of intermediate outcomes and sub-group
analyses.
3) To determine the incremental cost-effectiveness of
each telephone intervention compared to the reminder
letter and of enhanced tailored telephone counseling to
a reminder/scheduling call.
Methods/design
Study Design
Overall design
Figure 1 shows the overall design of the study. Begin-
ning in July, 2009, all eligible women are automatically
enrolled and randomized 1:1:1 to the three study arms.
After approval by PCPs and passive consent, women
are entered into the reminder study. The interventions
(letters and calls) are directed only to women who
have not had a mammogram in ≥ 18 months. The pri-
mary outcome is the proportion of all women who
have been enrolled for ≥ 24 months with a mammo-
gram within the previous 24 months. This outcome
will be determined at five times, at baseline and at the
end of each intervention year. Outcome at the end of
the last intervention year will be the single most
important result.
Participants
All women aged 51-84 in the Fallon Community Health
Plan (FCHP), for at least 24 months and have a primary
care practitioner (PCP) at Fallon Clinic (FC) are eligible
and are randomized to one of the three study arms.
Exceptions are women with bilateral mastectomies, in
hospice, in permanent nursing home care or those men-
tally incompetent. There are approximately 20,000 such
eligible women ages enrolled in the plan at any given
time. As women join the health plan or become 51,
once in the plan for 24 months, they are enrolled and
randomized into the study cohort. Enrollment into the
reminder intervention study requires Primary Care Phy-
sician (PCP) approval and passive consent of the
woman. PCPs are asked to exclude women using the
exclusion criteria (See Table 1). Participants are given
an opportunity to opt out of the study prior to being
intervened, at the time of any intervention and during
any phone call.
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Study Setting
Study team
The team includes University of Massachusetts research-
ers (the study joint principal investigators, project man-
ager, psychologist, health economist, biostatistician) and
the Fallon Clinic researchers (the site manager, physi-
cian liaison, data analyst, schedulers and counselors).
The study was approved by the Institutional Review
Board for the Fallon Clinic/Fallon Community Health
Plan Research Review Committee (IRB # 1191). The
study will be conducted in compliance with the Helsinki
Declaration.
Fallon Community Health Plan (FCHP) and Fallon Clinic Inc.
(FC)
FC is a multi-specialty medical group located in Central
Massachusetts with about 250 physicians and 20 medical
centers. FC is the main group practice affiliated with
FCHP, a mixed-model health maintenance organization
(HMO) primarily serving the Central Massachusetts
area. Automated tables in the FCHP “Data Warehouse”
include in- and outpatient visits, laboratory tests and
results, radiology procedures and membership. The FC
maintains a centralized data repository with automatic
feeds into the electronic record. Because most FC
women get their mammograms at FC radiology sites,
mammogram scheduled and completed dates are readily
accessible. Completion data from non-FC sites are cap-
tured in billing and medical records. Although racial
characteristics of FCHP members are not systematically
captured, they reflect that of the Worcester Metropoli-
tan area, which is about 90% White and 10% non-
White.
Health Plan reminder activities include
An automated reminder call to women a few days
before a scheduled mammogram appointment; an
annual report to PCPs with the names of women failing
to keep their mammogram appointments; at outpatient
visits, PCPs receive a reminder in the electronic health
record about overdue routine tests, including mammo-
graphy status. PCPs are neither rewarded nor penalized
for their responses.
Provider Responsibilities
109 of 111 FC PCPs agreed to: 1) participate in the
study and 2) allow their patients to join the study, 3)
review the list of their potentially eligible patients, 4)
eliminate those having an exclusion criterion and 5)
approve their electronic signature for personalized
reminder letters. Two PCPs declined steps 3-5 and
those functions were carried out by the FC study
clinician.
Interventions
Only women ≥ 18 months from a mammogram receive
study interventions. See Figure 2. When women are ≥
18 months from their last mammogram, they all receive
the same reminder letter. The letter is electronically
signed by a woman’s PCP and states: 1) there is no
record of a mammogram in the last 18 months, 2) get-
ting regular mammograms every 1-2 years is important
and 3) her PCP recommends that she call the Study
Scheduler for a mammogram appointment. When
women call, the Study Scheduler uses the same script
for all, except as noted below for women in the counsel-
ing arm. (See Table 2 for Study Scheduler Protocol)
RL Arm (reminder letter)
The reminder letter is the only intervention for
women in this arm
RC Arm (reminder letter followed by Study Scheduler call)
All women receive a reminder letter as above. If a
woman does not call following receipt of the remin-
der letter or does not schedule a mammogram on
her own within two weeks of the reminder letter,
Year 1 Year 2 Year 3 Year 4
           Identify new members age 51-84 and women turning 51,  enroll and randomize  to 3 study arms
Disenroll women who leave the  plan,  turn 85, request or whosePCPs  request disenrollment,
Measure Primary Outcome at Baseline and End of Each Study Year
Proportion of Women Enrolled >=24 mo. with a Mammogram within the Last 24 Months
Randomize
all
women
51-84 , in
plan >=24
mo. and
with current
plan PCP
to 3 Study
Arms
Figure 1 Overview of study design.
Table 1 Eligibility Criteria
Inclusion Criteria Exclusion Criteria
1. Age 51-84 1. History of bilateral mastectomies
2. Current patient of Fallon Clinic
PCP
2. Significant cognitive impairment
3. Currently enrolled in FCHP 3. Serious illness, precluding
screening
4. Has a working telephone 4. Life expectancy <5 years
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the Study Scheduler makes up to five call-attempts
to reach her. The script is the same as noted above.
ETTC Arm: (reminder letters and booklet followed by
Counselor call)
All women receive a reminder letter as above. If a
woman calls following receipt of the reminder letter,
the Study Scheduler uses the same script as in Table
2 but replaces item #4 with “Inform the woman that
she will receive a mammography booklet but will
not get a Counselor call unless she would like to”. If
a woman calls in to schedule or confirm a mammo-
gram appointment that is inappropriately far in the
future, the Scheduler sends a mammography booklet
and makes an appointment for her to receive a
Counselor call.
Randomize
Arm 3: Mailed Reminder
and Enhanced Telephone
Counseling
Reminder Call
 Wait 2 weeks
Reminder Letter
YES NO
Arm 1: Mailed
Reminder Only
Arm 2: Mail and
Telephone Reminder
Wait 2    Weeks
>=18 mo. since last
mammogram
Reminder Letter
Contacts Study Call Center:
Schedules?NO
>=18 mo. since last
mammogram
Mammogram within 12
months of Reminder Letter
Mammogram within 18 mo.
of Last Mammogram?
Wait
18 mo.
YES
NO
>=18 mo. since last mammogram
Mammogram within 12
months of Reminder Letter
Mammogram within 12
months of Reminder Letter
Mammogram within 18 mo. of
Last Mammogram?
NO
YES
NO
Mammogram within 18
mo.. of Last Mammogram?
NO
NO
Wait 12 mo.
from Letter
Second Reminder Letter and Booklet
Mailed
YESYES
NO
YES
YES
Women Eligible for  Intervention at Baseline or Becoming Eligible During 4 Year Intervention Period
Contacts Study Call Center:
Schedules?
Reminder Letter
Contacts Study Call Center:
Schedules?
Wait 2    Weeks
Enhanced TCC Counseling
Call
NO
YES
YES
NO
Figure 2 Overview of Intervention Protocol Implementation.
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If after receiving the reminder letter, a woman sche-
dules a mammogram on her own, there is no further
intervention. If a woman in the counseling arm does
not call within two weeks after the first reminder
letter, a mammography booklet is sent with a second
reminder letter that states that if she does not call or
schedule a mammogram within two weeks, a Coun-
selor will call her. If the woman does not respond to
the second reminder letter, the Counselor will make
five call-attempts.
Counseling calls typically last about 30-35 minutes.
If a subject requires a repeat counseling call during
the study period, the call content will be different
from that of the initial call. During repeat calls, the
Counselor will address any change in the subject’s
stage of readiness, beliefs and barriers. The Counse-
lor protocol using the CATI (computer assisted tele-
phone interviewing) system was detailed in our
previous publication [44,45].
Theoretical Basis of the Counseling Intervention:
1. Our counseling script incorporates a stage-based
theory of behavior change that emphasizes the evolution
of knowledge and personal risk perception in the devel-
opment of an intention to act, and the variables that
then influence acting on that intention [46,47]. The
stage-based models have attempted to integrate the con-
ceptual bases and empirical findings of the older models
of change to capture the complexities of health beha-
vior. The Precaution Adoption Process Model (PAPM)
[48,49] is useful in working with non-adherent women
because it classifies them into four stages that provide a
more detailed description of the earlier stages of deci-
sion-making. In designing the ETTC counseling algo-
rithm, we used our pilot mammography study to adapt
the PAPM stages (See Tables 3 &4) [44,45].
2. The ETTC counseling algorithm interviewing and
script use the following (MI) techniques [39]: 1)
expressing empathy through reflective listening skills
and a warm empathetic style; 2) developing discrepancy
between the patient’s current decision and future goals
so that the patient verbalizes the need for screening; 3)
avoiding argumentation; 4) “rolling with” resistance
instead of arguing with it; 5) involving the patient in
active problem solving; 6) supporting self-efficacy for
screening change by facilitating the patient’s own action
plan for mammography completion.
Counselor and Study Scheduler Recruitment, Training and
Supervision
The telephone counselors are women with Master’s level
education or counseling experience. The Counselors
train for two weeks in the detailed counseling protocol
by a clinical psychologist and an experienced telephone
counselor. Training includes: building adequate skills
using the CATI system, counseling protocol and materi-
als; role-playing all aspects of the intervention from sta-
ging patients to action planning and familiarizing the
Counselor with the scheduling procedures. Study Sche-
dulers are Bachelor’s prepared Research Assistants with
some research experience. The initial training for the
Table 2 Study Scheduler Script for Incoming Calls
1. Confirm eligibility.
2. Obtain verbal consent for the baseline survey.
3. Stage the subject if the subject is unsure about scheduling, using
Tables 3 and 4.
4. Schedule the mammogram. If the appointment is <= 24 months
from the prior mammogram, reaffirm the importance of keeping on a
12-24 month interval schedule, and remind her to keep the
appointment.
5. If a woman wants to schedule or confirm an appointment that is
inappropriately far in the future, deliver a brief message reminding the
woman that Fallon PCPs recommend mammograms every 12-24
months as the best way to find curable breast cancers. Offer to
schedule at a more appropriate interval.
6. Administer the brief baseline survey questions that has 6 socio-
demographic questions about ethnicity/race, educational level, working
status, smoking, marital and income status.
Table 3 Staging A Woman’s Readiness to Get A
Mammogram
STAGE PAPM STAGES REVISED
1 Unaware - of mammography and guidelines
2 Unengaged - aware but does not see need to get
mammogram
3 Undecided- considering the pros and cons of
mammograms
4A Definite No - would never get a mammogram
4B Qualified No - but might reconsider
5A Definite Yes - planning sometime
5B Definite Yes - planning soon but cannot set date
5C Definite Yes - planning soon and can set date
Table 4 Initial Staging Questions
• For those with no record of a mammogram: “Have you ever had a
mammogram"?
• If never had a mammogram: “Have you ever heard about a
mammogram” “Do you know what a mammogram is?”
• For those who have had a mammogram: “Are you planning or
thinking about getting a mammogram?”
• If planning: “Within 3 months?” “More than 3 months?” “ Don’t know
when”
• If planning: “Can I schedule you now? When?”
• If not planning: “Have you decided not to get a mammogram?”
• If decided no: “Have you thought seriously about whether
mammograms are for you?”
“Are you unable to decide to get a mammogram?” “Do you mean
you would never get
a mammogram or you would not get a mammogram unless
something happened?”
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Study Scheduler takes 20 hours. Both Counselors and
Study Schedulers received didactic presentations on
research methods, study goals, breast cancer and mam-
mography screening, systems-based interventions to
increase mammography use, screening rates in minority
populations and role-playing with study staff and
“mock” patients. Selected telephone calls are audio
taped and reviewed by the study project manager for
quality control and to insure fidelity to protocol. Appro-
priate refresher/corrective sessions are undertaken as
needed.
Repeat interventions (booster doses)
There are very few studies examining the effect of
repeat interventions [13,50-53]. Since the intervention
period will span 48 months, we will be able to evaluate
the booster effect more fully.
Outcomes
The primary outcome is the proportion of women con-
tinuously enrolled for ≥24 months who have had ≥1
mammogram in the last 24 months. This measure
mimics the standard HEDIS (Healthcare Effectiveness
and Data Information Set) measure used by most health
plans and systems to track mammography utilization,
although the HEDIS measure is usually applied only to
women age 50-69. The measure is a cross-sectional, pre-
valence measure that can be applied in a series of static
“snapshots” to a dynamically changing population like
the one in our study and in any typical health plan.
The secondary outcomes are 1) the number of women
in each arm requiring repeat interventions and 2) the
immediate outcomes (change in stage of readiness,
mammography scheduling for those in the RC and
ETTC arms during calls) and short term outcomes
(receiving a mammogram within 3 months) following
the interventions, for all women receiving the interven-
tions for the first time, adjusted as needed by appropri-
ate covariates (e.g. age, time to last mammogram,
marital status and other factors).
The main cost-effectiveness outcome is the incremen-
tal cost-effectiveness of each intervention combination,
that is, the difference in the percentage of eligible
women with mammograms divided by the difference in
total cost for each intervention pair. The study also
measures separately the startup and operating costs of
each intervention.
Data Collection and Management
During the four-year intervention period the claims
database and the electronic health record data base are
searched weekly to determine eligibility of women to
receive a reminder letter. Study staff enter data on study
enrollment when they receive information from PCPs
and/or from women relevant to enrollment. The only
data required for primary outcome measures on women
enrolled in the study are duration of enrollment in
FCHP/FC, dates of mammograms, and birth date for
developing age-specific outcomes.
Secondary analyses will include subgroup analyses
involving the primary outcome, analyses involving sec-
ondary outcomes (e.g. change in stage of readiness from
beginning to the end of reminder and ETTC calls, com-
pletion of scheduled mammograms and time from inter-
vention to mammogram completion) and other analyses
requiring independent variables collected from the
FCHP database and during all calls from and to subjects.
Medicare and Medicaid insurance coverage, history of
claims for preventive checkups and other screening tests
(e.g. Pap smears, cholesterol, colon cancer screening)
will be obtained from FCHP claims databases and the
electronic health record database to compare adherence
to mammography recommendations to the utilization of
other preventive services. (Table 5 shows all of the data
sources)
The cost effectiveness analysis will measure all costs
from the provider perspective. We will estimate start-up
costs and fully staffed operational and cost estimates to
give potential adopters a sense of the investment
required to implement and maintain each intervention.
Start up costs include database and software develop-
ment and installation, equipment purchases, training
costs, and overall administrative costs for the RC and
Table 5 Data Sources for Analysis
Data Sources Primary
Outcome
Analysis
Secondary
Data Analyses
Process
Analysis
FCHP and FC
Membership Database
X X X
FCHP Claims Database
and
Electronic Health
Record database
X X X
Fallon Clinic Scheduling
System
X X
Patient Survey
(Administered to
subjects
calling the Study
Scheduler or
receiving reminder or
ETTC calls)
X
ETTC and Reminder
Call CATI System
& Tracking Database
X X
Phone Call Logs X
PCP Approvals for
Patient Enrollment
X X X
Patient Refusals of
Enrollment
X X
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ETTC interventions. Operational costs include staff and
administration salaries, overhead costs (office space,
phone, electric, etc.), office supplies, information system
and equipment maintenance, and postage. We employ a
“micro-costing” approach where units for each compo-
nent of resource use are measured directly, a unit cost
is applied for each and units are multiplied by unit cost
to get cost estimates. Staff time and effort involved for
all tasks in the intervention are measured using staff
logs.
Sample Size and Power
Power and Sample Size
Given, the typical size of the female population ages 51-
84 at FCHP/FC of 25,000, we estimated there would be
at minimum 15,000 women available for the analyses
involving the primary outcome at each year. We
explored power to detect differences in primary out-
come among intervention groups under two scenarios.
Based on findings from our EPICS study [27] we believe
that it is reasonable to expect differences of 3-5% or
greater across groups. Differences that are smaller
would likely be of little interest to health plans. In the
first scenario we assumed that the primary outcome in
the RL group remains at 75%, as it is now and that the
outcome in the RC group is 80% and in the ETTC 85%.
In the second scenario we assumed these outcomes: RL
80%, RC 83% and ETTC 86%. With 15,000 in the sam-
ple (5,000 per group) there is greater than 99% power to
detect the differences proposed or larger ones across
groups under both scenarios. For the trends over time
there will be approximately 90% power for an increasing
trend over five years leading to a 5% increase in any
group (e.g..75 to.80) based on Cochran-Armitage test of
trend with power calculations described by Hintze [54].
Power calculations were carried out using Power Analy-
sis and Sample Size (PASS) 2008.
Proportion needing repeat interventions
The comparison of rates of repeat interventions will be
made between the two call arms of the study (RC and
ETTC). We identified sufficient power (greater than
85%) for differences in proportion needing repeat inter-
vention of 6% (80% vs. 86% for example).
Statistical Methods
Primary Outcome Analysis: HEDIS-like measure over time
The unit of randomization and analysis is the individual
woman. The primary outcome measure is the propor-
tion of women continuously enrolled for 24 months
with ≥1 mammogram in the past 24 months. This will
be evaluated at the five measurement time points. The
main study finding of interest will be the comparison of
this proportion across groups after the last year of inter-
vention (Year 4), because we believe this result best
illustrates the magnitude of intervention effect that
would be achieved in all future years. The second
hypothesis is that the primary outcome measure may
change differently over time in the telephone interven-
tion groups because there may be some cumulative
effect of repeated interventions on women who do not
respond the first time. It is also possible that the inter-
ventions may become less effective when applied repeat-
edly to the same group of women over time. Changes in
the composition of the patient population over time
could also cause changes in the outcomes. We will esti-
mate the trend over time of the primary outcome within
each intervention group and compare the trends over
time among the randomized groups. The third hypoth-
esis is that lower age will be associated with a greater
response to less intensive interventions. We will investi-
gate this hypothesis through analyses assessing the inter-
action of subgroups and the intervention arms. To
accomplish this and some related analyses involving the
primary outcome, we will examine the interactions with
intervention group of age, type of medical insurance,
and time since last mammogram. Analyses will be car-
ried out using generalized linear models. More specifi-
cally, logistic regression models will provide estimates of
associations of factors (including the intervention
groups) with the primary outcome of mammography
screening and adjustment for possible confounders. For
models over time with the panel data we will appropri-
ately adjust for correlations using robust variance
estimation.
Secondary Outcomes Analyses
We hypothesize that fewer women who receive the
intensive telephone intervention will require a repeat
telephone intervention in subsequent years compared to
women receiving the brief intervention. For this analysis
we will assemble two cohorts of women, one that
received ETTC and subsequently received a mammo-
gram within 12 months of the call and another that
received a reminder call (RC) and also received a mam-
mogram within 12 months of the call. Proportions sche-
duling a mammogram within 18 months of the index
mammogram and completing a mammogram within 19
months of the index mammogram will be compared
between the two intervention arms.
The second hypothesis is that more women who sche-
dule a mammogram after intensive counseling than after a
brief reminder call will complete the mammogram. Other
secondary analyses will include: 1) analysis of immediate
term outcomes (change in stage of readiness, mammogra-
phy scheduling) and short term outcomes (receiving a
mammogram within three months) following telephone
interventions, for all women receiving the interventions
for the first time, adjusted as needed by appropriate cov-
ariates (e.g. age, time to last mammogram, marital status
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and other factors), 2) response to reminder letters mea-
sured by the proportion of women without a recent mam-
mogram scheduled or completed who schedule a
mammogram within two weeks of a reminder letter, com-
pared to the proportion of women scheduling during
other two week intervals, adjusted for age, time to last
mammogram, and other factors as appropriate.
Cost and Cost-Effectiveness Analyses (CEA)
Following similar studies of methods to increase mam-
mography screening, we will conduct the analysis from
the perspective of the payer/provider, FCHP/FC
[55,56], rather than from the perspective society typi-
cally advocated by cost-effectiveness guidelines. Our
rationale is that provider costs are the most relevant
measure for groups considering adopting the study
interventions. Separate comparisons will be conducted
for each intervention year including calculating total
startup costs for the ETTC and the RC group; calculat-
ing the cost of operating each intervention by sum-
ming costs for each intervention in each of the four
intervention years. Costs for ETTC and RC will be cal-
culated by amortizing startup costs across the four-
year intervention period and adding the operating
costs in each year of the intervention. Costs for RL
intervention will be based on operating costs only.
Recent cancer screening studies have compared differ-
ences in total, rather than average, costs across inter-
ventions [55-57]. To estimate the incremental cost-
effectiveness of each intervention combination, we will
compare the difference in the percentage of eligible
women with mammograms divided by the difference in
total cost for each intervention pair. We will report
initial results as the incremental cost of increasing on-
time mammograms by 1%. This figure can also be con-
verted to an estimated cost per additional mammo-
gram for a hypothetical sample of women. We will
conduct sensitivity analyses to determine the effect of
including or excluding startup costs, excluding admin-
istrative overhead costs, amortizing startup costs over
a longer or shorter period, higher or lower (e.g. 10%)
costs for each intervention and higher or lower effec-
tiveness (e.g. 5% and 10% variation.)
Randomization
Patients joining the FCHP are automatically entered into
our tracking system if they are female, aged 51-84, have a
FC primary care provider and are in the plan for 24
months. Once identified and loaded onto the tracking sys-
tem, they are automatically randomized to one of the three
study arms. No blocking or stratification is used. The
tracking database server uses a built-in T-SQL function to
randomly allocate a number from 1-3 to each patient. The
numbers refer to the specific intervention arm assignment.
Documentation of the function can be found at: http://
msdn.microsoft.com/en-us/library/ms177610.aspx
Blinding
Since women receive different intervention depending
on the arm to which they were randomized, blinding of
subjects and the staff that receives and makes calls is
not possible. Although a woman might reveal what type
of contact she had had with study personnel in discus-
sion with her PCP, PCPs are not informed as to which
arm a patient is in. While the intervention assignment
and the individual mammography outcome is not
blinded, overall study arm outcomes will be blinded for
all study personnel while the study is ongoing. The sta-
tistical team will conduct outcome analyses only at the
conclusion of the intervention phase.
Baseline results
Since July 2009, 18,509 female FCHP/FC enrollees aged
51-84 have been enrolled into our tracking database and
were randomized into one of three arms. Table 6 shows
their mammogram status at randomization. Table 7
shows the characteristics of the study sample, their
approval or non-consent status by age. At baseline,
5,223 women were eligible for an intervention.
Discussion
The interventions we will evaluate and compare in this
study represent system solutions to reminding, schedul-
ing, counseling and motivating women to get regular
repeated mammograms. These interventions represent
an effort to remove much of the reminder/counseling
burden from PCPs and their practice staff. In particular,
we are interested in evaluating the effectiveness of a
centralized reminder and counseling system as alterna-
tive to the primary care providers’ (PCPs) role in
reminding, educating and/or motivating women to get
screening mammography. While many women may be
brought to regular on time screening with minimal
reminders, women who are significantly overdue for
screening or habitually non-compliant need more than
Table 6 Mammogram Status at Study Entry*
Last Mammogram <8 mo. ago 18-23 mo. ago 24-29 mo. ago 30-35 mo. ago 26-48 mo. ago >48 mo. ago
N = 18,509
(100.0%)
12,808
(69.20)
986
(5.33)
866
(4.68)
599
(3.24)
851
(4.60)
1,758
(9.50)
* Columns do not total to 100% because of missing data.
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reminders. We believe counseling and motivating these
women will be required. Unfortunately, providers have
not been consistently involved in lengthy education or
counseling the more reluctant women due to time con-
straints, limited patient responsiveness, limited PCP
training in counseling and limited reimbursement for
providing preventive services [58]. Even when providers
undertake counseling, it may be brief, incomplete and/
or relatively ineffective due to limited time and training
[59-63]. All these problems are compounded by the fact
that the numbers of new physicians entering primary
care are decreasing significantly and the need for physi-
cian extenders is increasing [64]. Finding cost-effective
ways to complement PCPs recommendations is critical
and the results of this study will be illuminating. In
addition, since this study aims to identify the most effec-
tive and most cost effective of the outreach strategies,
the forthcoming result will provide much needed and
timely guidance for health plans [1] and ACOs.
Since the intervention period will span 48 months, we
will be able to evaluate the effect of repeated interven-
tions more fully than others have [53]. We hypothesize
that woman who respond to an initial intervention may,
when coming due for another mammogram, either
requires no intervention or a less intense intervention
than they responded to initially.
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